Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer

被引：0
|
作者：
Mikiya Ishihara
Hirofumi Mukai
Shunji Nagai
Toru Mukohara
机构：
[1] National Cancer Center Hospital East,Division of Oncology/Hematology
来源：
International Journal of Clinical Oncology | 2009年 / 14卷
关键词：
Adjuvant drug therapy; Breast cancer; Cardiac safety; Japanese patients; Trastuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 435
页数：4
相关论文
共 50 条
  • [1] Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
    Ishihara, Mikiya
    Mukai, Hirofumi
    Nagai, Shunji
    Mukohara, Toru
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 431 - 435
  • [2] The cardiac safety of trastuzumab in the treatment of breast cancer
    Chien, A. Jo
    Rugo, Hope S.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2010, 9 (02) : 335 - 346
  • [3] Adjuvant Trastuzumab Treatment without Adjuvant Chemotherapy in Early Breast Cancer
    Dall, P.
    Koch, T.
    Lenzen, G.
    Kuhn, T.
    Hielscher, C.
    Reichert, D.
    Maasberg, M.
    Ehscheidt, P.
    Eustermann, H.
    Fischer, G.
    [J]. CANCER RESEARCH, 2011, 71
  • [4] TRASTUZUMAB AS ADJUVANT THERAPY IN HER2+ EARLY BREAST CANCER - CARDIAC SAFETY ANALYSIS
    Ferreira, M.
    Soares, R. H. V. S.
    Godinho, J.
    Shvets, Y.
    Couto, N.
    Afonso, N.
    Pereira, D.
    Rodrigues, H.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 90 - 90
  • [5] Adjuvant trastuzumab in early breast cancer
    Mariani, G.
    Gianni, L.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : X54 - X58
  • [6] Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer
    Marinko, Tanja
    Borstnar, Simona
    Blagus, Rok
    Dolenc, Jure
    Bilban-Jakopin, Cvetka
    [J]. RADIOLOGY AND ONCOLOGY, 2018, 52 (02) : 204 - 212
  • [7] Trastuzumab in the adjuvant treatment of breast cancer
    Svetlovska, D.
    Mardiak, J.
    Kristova, V
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2007, 108 (02): : 100 - 103
  • [8] Safety of adjuvant trastuzumab (T) in elderly patients with breast cancer.
    Militello, L.
    Carli, P.
    Spazzapan, S.
    Lestuzzi, C.
    Miolo, G.
    Scalone, S.
    Veronesi, A.
    Crivellari, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [9] Cardiac safety guidelines for the adjuvant use of trastuzumab (Herceptin®) in HER2-positive early breast cancer
    Ewer, M. S.
    Perez, E. A.
    Baselga, J.
    Bell, R.
    Brutsaert, D.
    Marty, M.
    Pienkowski, T.
    Suter, T. M.
    [J]. BREAST, 2007, 16 : S63 - S63
  • [10] Cardiac safety of docetaxel/cyclophosphamide/trastuzumab (DCH) as adjuvant therapy for HER-2 (+) early stage breast cancer
    Mato, A.
    Cappa, M.
    Fox, K.
    Policarpo, G.
    Cohen, J.
    Wall, H.
    Rossi, S.
    Mintzer, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345